Trust Company of Oklahoma’s Pfizer PFE Stock Holding History

Trust Company of Oklahoma’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,528	Closed	-$386K	–	145
2022 Q4	$386K	Buy	+7,528	New	+$361K	0.16%	105
2022 Q1	–	Sell	-3,495	Closed	-$206K	–	125
2021 Q4	$206K	Buy	+3,495	New	+$173K	0.07%	124
2019 Q3	–	Sell	-6,231	Closed	-$256K	–	126
2019 Q2	$256K	Sell	6,231 -150	-2%	-$5.96K	0.11%	118
2019 Q1	$257K	Sell	6,381 -1,080	-14%	-$43.3K	0.12%	117
2018 Q4	$309K	Buy	7,461 +316	+4%	+$13.1K	0.16%	98
2018 Q3	$299K	Sell	7,145 -1,686	-19%	-$64.9K	0.14%	112
2018 Q2	$304K	Hold	8,831	–	–	0.15%	108
2018 Q1	$297K	Buy	8,831 +63	+0.7%	+$2.17K	0.14%	107
2017 Q4	$301K	Buy	+8,768	New	+$299K	0.14%	104

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trust Company of Oklahoma's PFE Position: Q1 2023 in Review

Trust Company of Oklahoma sold out of Pfizer (PFE) in Q1 2023, closing a stake of 7,528 shares — an estimated $386K sold.

Trust Company of Oklahoma first reported a position in PFE in Q4 2017 and held it in 9 quarters. The position peaked at $386K in Q4 2022. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Trust Company of Oklahoma reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Trust Company of Oklahoma sold 7,528 Pfizer shares in Q1 2023, an estimated $386K.
Trust Company of Oklahoma first reported a position in Pfizer in Q4 2017 and held it in 9 quarters.
Trust Company of Oklahoma's Pfizer position peaked at $386K in Q4 2022.
3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Trust Company of Oklahoma's 13F filing for Q1 2023, filed 14 Apr 2023.